Add-on Cangrelor in STEMI-triggered Cardiac Arrest
Pharmacokinetic/Pharmacodynamic Effects of add-on Antiplatelet Therapy With Parenteral Cangrelor as Compared to Standard Dual Antiplatelet Treatment in Patients With ST-elevation Myocardial Infarction Complicated by Out-of-hospital Cardiac Arrest and Treated With Targeted Temperature Management
Sponsor: Medical University of Vienna
This PHASE4 trial investigates ACS - Acute Coronary Syndrome and Cardiopulmonary Arrest With Successful Resuscitation and is currently ongoing. Medical University of Vienna leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE4
▶ Show 1 earlier version
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical University of Vienna
For direct contact, visit the study record on ClinicalTrials.gov .